Eden Research (LON:EDEN) Stock Price Passes Below Fifty Day Moving Average – Time to Sell?

Eden Research plc (LON:EDEN)’s stock price crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 2.91 ($0.04) and traded as low as GBX 2.42 ($0.03). Eden Research shares last traded at GBX 2.49 ($0.03), with a volume of 703,330 shares trading hands.

Eden Research Price Performance

The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The firm has a market capitalization of £13.30 million, a price-to-earnings ratio of -562.73 and a beta of 0.92. The business’s fifty day simple moving average is GBX 2.91 and its 200 day simple moving average is GBX 3.21.

Eden Research (LON:EDEN) last released its quarterly earnings data on Wednesday, September 17th. The company reported GBX (0.25) earnings per share (EPS) for the quarter. Eden Research had a negative return on equity of 11.63% and a negative net margin of 38.70%. On average, research analysts forecast that Eden Research plc will post -66.0000038 EPS for the current year.

Insider Activity at Eden Research

In other news, insider Alexander John Abrey bought 360,490 shares of the stock in a transaction dated Wednesday, September 17th. The shares were bought at an average cost of GBX 3 per share, with a total value of £10,814.70. Also, insider Sean M. Smith bought 390,624 shares of the business’s stock in a transaction that occurred on Wednesday, September 17th. The stock was purchased at an average price of GBX 3 per share, for a total transaction of £11,718.72. Insiders own 4.46% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.